Bolivar s Citizens Memorial Hospital part of clinical study for groundbreaking Alzheimer s treatment drug ky3.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ky3.com Daily Mail and Mail on Sunday newspapers.
Simon Belenkiy, left, and Sulamif Belenkaya were given monoclonal antibodies to combat COVID-19. (Courtesy)
Illustrative: In this undated image from video provided by Regeneron Pharmaceuticals on Friday, October 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. (Regeneron via AP)
This photo provided by Eli Lilly shows the drug bamlanivimab. On Monday, November 9, 2020, the Food and Drug Administration cleared emergency use of bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. (Courtesy of Eli Lilly via AP)
Asante begins offering antibody treatment for COVID-19 patients
Asante said that it is one of four healthcare providers in Oregon offering the monoclonal antibody treatment, due to emergency use approval from the FDA.
Posted: Jan 27, 2021 11:37 AM
Posted By: Jamie Parfitt
ASHLAND, Ore. Asante announced on Wednesday that it is now offering monoclonal antibody treatment for coronavirus patients following emergency use approval of the experimental treatments by the FDA.
“The treatment can have a significant impact on the severity of symptoms people experience as well as help reduce the need for more intense hospital-related interventions,” said Lee Shapley, MD, administrator at Asante Ashland Community Hospital. “By treating people at the early onset of their COVID diagnosis, this therapy can help people recover faster with fewer lingering effects of the disease and keep more people out of the hospital.”